KR19980703647A - 베나제프릴 또는 베나제프릴라트 및 발사르탄을 함유하는조성물 - Google Patents
베나제프릴 또는 베나제프릴라트 및 발사르탄을 함유하는조성물 Download PDFInfo
- Publication number
- KR19980703647A KR19980703647A KR1019970707046A KR19970707046A KR19980703647A KR 19980703647 A KR19980703647 A KR 19980703647A KR 1019970707046 A KR1019970707046 A KR 1019970707046A KR 19970707046 A KR19970707046 A KR 19970707046A KR 19980703647 A KR19980703647 A KR 19980703647A
- Authority
- KR
- South Korea
- Prior art keywords
- active ingredient
- formula
- valsartan
- ingredient component
- benazepril
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/556—Angiotensin converting enzyme inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH1012/95 | 1995-04-07 | ||
CH101295 | 1995-04-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR19980703647A true KR19980703647A (ko) | 1998-12-05 |
Family
ID=4200393
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019970707046A KR19980703647A (ko) | 1995-04-07 | 1996-04-02 | 베나제프릴 또는 베나제프릴라트 및 발사르탄을 함유하는조성물 |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP0820302A1 (fr) |
JP (1) | JPH11503139A (fr) |
KR (1) | KR19980703647A (fr) |
CN (1) | CN1181019A (fr) |
AU (1) | AU5399096A (fr) |
BR (1) | BR9604818A (fr) |
CA (1) | CA2214143A1 (fr) |
CZ (1) | CZ313897A3 (fr) |
HU (1) | HUP9801593A2 (fr) |
MX (1) | MX9707683A (fr) |
NO (1) | NO974400D0 (fr) |
PL (1) | PL322529A1 (fr) |
SK (1) | SK133897A3 (fr) |
TR (1) | TR199701121T1 (fr) |
WO (1) | WO1996031234A1 (fr) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2224451A1 (fr) * | 1995-06-30 | 1997-01-23 | Merck & Co., Inc. | Procede de traitement de nephropathies a l'aide d'un inhibiteur de l'ace et d'un antagoniste de l'a ii |
CN101011390A (zh) | 1999-01-26 | 2007-08-08 | 诺瓦提斯公司 | 血管紧张素ⅱ受体拮抗剂在治疗急性心肌梗塞中的应用 |
HUP0400475A3 (en) * | 2000-04-12 | 2006-02-28 | Novartis Ag | Pharmaceutical compositions containing combination of at least two compounds selected from an at1-receptor antagonist or an ace inhibitor or a hmg-co-a reductase inhibitor groups and use thereof |
AU2001289672B2 (en) | 2000-07-19 | 2005-12-08 | Novartis Ag | Valsartan salts |
GB0020691D0 (en) * | 2000-08-22 | 2000-10-11 | Boehringer Ingelheim Pharma | Pharmaceutical combination |
PL366419A1 (en) * | 2000-08-22 | 2005-01-24 | Boehringer Ingelheim Pharma Bmbh & Co.Kg | Pharmaceutical combination of angiotensin ii antagonists and angiotensin i converting enzyme inhibitors |
CZ20031678A3 (cs) * | 2000-12-18 | 2003-10-15 | Novartis Ag | Terapeutická kombinace amlodipinu a benazeprilu |
US6869970B2 (en) * | 2002-02-04 | 2005-03-22 | Novartis Ag | Crystalline salt forms of valsartan |
CN100377744C (zh) * | 2002-07-05 | 2008-04-02 | 安徽省生物医学研究所 | 一种预测acei类降压药药效的复方药 |
WO2004019876A2 (fr) * | 2002-08-28 | 2004-03-11 | Curis, Inc. | Administration conjointe de morphogenes et d'inhibiteurs de conversion de l'enzyme de l'angiotensine pour le traitement de l'insuffisance renale chronique |
EP1908469A1 (fr) * | 2006-10-06 | 2008-04-09 | Boehringer Ingelheim Vetmedica Gmbh | Antagonistes du récepteur de l'angiotensine II pour traiter des désordres sistémiques des chats |
CN101869710A (zh) * | 2009-04-24 | 2010-10-27 | 北京奥萨医药研究中心有限公司 | 降压药物组合物 |
WO2010133638A1 (fr) | 2009-05-20 | 2010-11-25 | Boehringer Ingelheim Vetmedica Gmbh | Solution pharmaceutique buvable de telmisartan |
US20110009347A1 (en) | 2009-07-08 | 2011-01-13 | Yin Liang | Combination therapy for the treatment of diabetes |
EP3099328A1 (fr) * | 2014-01-31 | 2016-12-07 | Janssen Pharmaceutica NV | Procédés de traitement et de prévention de troubles rénaux et de troubles graisseux du foie |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR970005839B1 (ko) * | 1990-05-11 | 1997-04-21 | 화이자 인코포레이티드 | 상승 치료효과를 얻기 위한 조성물 및 방법 |
EP0629408A1 (fr) * | 1993-06-16 | 1994-12-21 | LABORATOIRES MERCK, SHARP & DOHME-CHIBRET | Combination d'inhibiteurs ACE et d'antagonistes AII |
-
1996
- 1996-04-02 HU HU9801593A patent/HUP9801593A2/hu unknown
- 1996-04-02 BR BR9604818A patent/BR9604818A/pt not_active Application Discontinuation
- 1996-04-02 SK SK1338-97A patent/SK133897A3/sk unknown
- 1996-04-02 PL PL96322529A patent/PL322529A1/xx unknown
- 1996-04-02 MX MX9707683A patent/MX9707683A/es unknown
- 1996-04-02 KR KR1019970707046A patent/KR19980703647A/ko not_active Application Discontinuation
- 1996-04-02 AU AU53990/96A patent/AU5399096A/en not_active Abandoned
- 1996-04-02 CZ CZ973138A patent/CZ313897A3/cs unknown
- 1996-04-02 CA CA002214143A patent/CA2214143A1/fr not_active Abandoned
- 1996-04-02 TR TR97/01121T patent/TR199701121T1/xx unknown
- 1996-04-02 EP EP96910948A patent/EP0820302A1/fr not_active Withdrawn
- 1996-04-02 JP JP8529972A patent/JPH11503139A/ja active Pending
- 1996-04-02 WO PCT/EP1996/001440 patent/WO1996031234A1/fr not_active Application Discontinuation
- 1996-04-02 CN CN96193111A patent/CN1181019A/zh active Pending
-
1997
- 1997-09-23 NO NO974400A patent/NO974400D0/no unknown
Also Published As
Publication number | Publication date |
---|---|
CN1181019A (zh) | 1998-05-06 |
HUP9801593A2 (hu) | 1999-01-28 |
TR199701121T1 (xx) | 1998-03-21 |
CZ313897A3 (cs) | 1998-01-14 |
EP0820302A1 (fr) | 1998-01-28 |
BR9604818A (pt) | 1998-06-09 |
NO974400L (no) | 1997-09-23 |
JPH11503139A (ja) | 1999-03-23 |
SK133897A3 (en) | 1998-02-04 |
PL322529A1 (en) | 1998-02-02 |
CA2214143A1 (fr) | 1996-10-10 |
MX9707683A (es) | 1997-12-31 |
NO974400D0 (no) | 1997-09-23 |
WO1996031234A1 (fr) | 1996-10-10 |
AU5399096A (en) | 1996-10-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2322174B1 (fr) | Utilisation combinée de valsartane et bloqueurs du canal de calcium à but thérapeutique | |
KR19980703647A (ko) | 베나제프릴 또는 베나제프릴라트 및 발사르탄을 함유하는조성물 | |
US6395728B2 (en) | Method of treatment and pharmaceutical composition | |
RU2334513C2 (ru) | Фармацевтические композиции, включающие валсартан и ингибиторы нейтральной эндопептидазы (nep) | |
RU2316318C2 (ru) | Фармацевтическая композиция, включающая ингибитор ренина, блокатор кальциевых каналов и диуретик | |
TWI508726B (zh) | 治療心房纖維性顫動之方法 | |
CZ305341B6 (cs) | Farmaceutická kompozice, souprava obsahující účinné látky této kompozice a použití kombinace účinných látek této kompozice | |
US6204281B1 (en) | Method of treatment and pharmaceutical composition | |
Morganti et al. | Aliskiren: the first direct renin inhibitor available for clinical use | |
Szucs | Cilazapril: a review | |
JPH04230220A (ja) | 医薬組成物 | |
JP4609877B2 (ja) | 慢性拒絶反応抑制剤 | |
RU2298405C2 (ru) | Применение антагонистов рецептора ангиотензина ii для лечения острого инфаркта миокарда | |
WO2004075892A2 (fr) | Traitement combine de l'hypertension au moyen de lercanidipine et d'un bloqueur des recepteurs de l'angiotensine ii | |
ZA200106022B (en) | Use of angiotensin II receptor antagonists for treating acute myocardial infarction. | |
Su et al. | Comparison between angiotensin receptor antagonism and converting enzyme inhibition in heart failure: Differential acute effects according to the renin-angiotensin system activation | |
TWI281858B (en) | Pharmaceutical combination of angiotensin II antagonists and angiotensin I converting enzyme inhibitors | |
Sierra et al. | Role of the selective aldosterone receptor blockers in arterial hypertension | |
Waeber et al. | Antihypertensive Agents: Mechanisms of Drug Action | |
WO2003007964A1 (fr) | Remede ou agent preventif de cardiopathie ou d'anevrysme contenant un compose d'inhibition de la chymase | |
KR20230006884A (ko) | 뇌 아미노펩티다제 a 억제제, 이뇨제, 및 전신 레닌-안지오텐신 시스템의 차단제를 포함하는 약학 병용물 | |
Padia et al. | Renin inhibition as a new strategy to combat cardiovascular disease | |
Ks Siegl et al. | Cardiovascular and Renal Review: Pharmacology of Angiotensin II Receptor Antagonists: Comparison with Renin Inhibitors and Angiotensin-Converting Enzyme Inhibitors | |
WO2004035051A1 (fr) | Polytherapie a base de lisinopril/lercanidipine | |
MXPA01000322A (en) | Method of treatment and pharmaceutical composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |